The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease ...

“The TP53 mutation (pathogenic variant) was not present throughout the donor’s body tissues, meaning he had not inherited it. The mutation would appear to have arisen in the testes but to have ...

Younger age at diagnosis did not appear to affect outcomes among women with breast cancer who harbor BRCA mutations, ...

A number of British women have received sperm from a donor with a cancer-causing gene while seeking fertility treatment ...

“Love, Danielle” is not a documentary, but it incorporates real surgical footage from its co-writer and star, Devin Sidell, ...

How likely are you to get breast cancer when you hit 60? What you need to know - The impact of breast cancer on women over 60 ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

A local law professor’s search for answers has driven her to advocate for women’s health and speak out about the silent ...

Testing for changes in breast cancer genes that can be inherited and greatly increase a person’s risk of getting certain ...

Kenya inching closer to Precision Cancer Care as AstraZeneca and the Aga Khan University Hospital, Nairobi Announce BRCA ...